ARTICLE | Company News
Xellia Pharmaceuticals A/S, SINTEF, Statens Serum Institute deal
March 4, 2013 8:00 AM UTC
Xellia partnered with SINTEF's SINTEF Materials and Chemistry research group and the Statens Serum Institute to develop antibiotics against Gram-negative bacterial infections, including those caused b...